Global Protein Tyrosine Kinase 7 Market Overview
The PTK7 gene encodes a receptor tyrosine kinase called tyrosine-protein kinase-like 7, also known as colon carcinoma kinase 4 (CCK4). Extracellular signals are carried through the cell membrane by receptor protein tyrosine kinases. A tyrosine kinase is a cellular enzyme that transfers a phosphate group from ATP to a protein. Kinase inhibitors are enzymes that prevent cancerous cells from dividing and growing. Protein kinases are involved in a number of cell functions, including cell cycle, differentiation, proliferation, and apoptosis. In cancer, these cell processes are used to regulate a variety of cell activities. PTKs are divided into two categories: non-receptor cytoplasmic PTKs (NRTKs) and transmembrane receptor PTKs. The position of non-receptor tyrosine kinase and receptor tyrosine kinase is the only difference. Non-receptor tyrosine kinase are found in the cell's cytoplasm, while receptor tyrosine kinase are found on the cell's surface, especially the cell membrane. The global protein tyrosine kinase 7 market is anticipated to register a CAGR of 5.8%.
Impact of Covid-19 pandemic on market
Global Protein Tyrosine Kinase 7 Market Dynamics
Growth in business operations by emerging and small sized players
Increased recognition of kinase inhibitors, a boom in product approvals, an increase in the incidence of cancer diseases, and increased investment from pharmaceutical companies are some of the main factors driving market growth. Furthermore, the increased use of kinase inhibitors for newer applications, as well as emerging economies such as China, India, and others, will open up new opportunities for the global kinase inhibitors industry. Several advances and advanced therapeutics have been developed with the aid of cancer treatment research and development activities. High production costs, on the other hand, result in a higher post-approval sales price for the medication. As a result, the drug's price has stifled market expansion to some degree.
Global Protein Tyrosine Kinase 7 Market Segmentation
The global protein tyrosine kinase 7 market is segmented based on product, application, distribution channel and region.
On the basis of product, the global protein tyrosine kinase 7 market is segmented into Epidermal growth factor receptor tyrosine kinase inhibitors, BCR-ABL tyrosine kinase inhibitor, vascular endothelial growth factor tyrosine kinase inhibitor and others. Based on Application, the target market is segmented into lung cancer, chronic myeloid leukemia, Renal cell cancer and breast cancer. On the basis of distribution channel, the target market is segmented into hospital pharmacies, online pharmacies and Independent pharmacies.
Regional Insights:
On region the global Protein Tyrosine Kinase 7 market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market is expected to be dominated by North America. North America's market is largely driven by the high cost of TKIs and high health-care spending. Demand for innovative treatment solutions such as personalized treatments has also led to the region's dominant position.
Report Scope:
|
Attribute |
Details |
|
Base year for estimation |
2020 |
|
Forecast period |
2020 – 2030 |
|
Market representation |
Revenue in USD Million & CAGR from 2020 – 2030 |
|
Market Segmentation |
By Product- Epidermal growth factor receptor tyrosine kinase inhibitors, BCR-ABL tyrosine kinase inhibitor, vascular endothelial growth factor tyrosine kinase inhibitor and others. By Application– lung cancer, chronic myeloid leukemia, Renal cell cancer and breast cancer By Distribution channel– hospital pharmacies, online pharmacies and Retail pharmacies |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2030. For the purpose of this study, has segmented the global protein tyrosine kinase 7 market report based on product, application, distribution channel and region.
Global Protein Tyrosine kinase 7 Market, By Region:
-
-
- North America
-
- U.S.
- Canada
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- North America
-
Global Protein Tyrosine Kinase 7 Market Key Players
The key players operating in the global protein tyrosine kinase 7 market includes Novartis AG, Bristol-Myers Squibb Company, Pfizer Inc., and Johnson & Johnson AstraZeneca Plc, Bayer AG, Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd., , Eisai Co., Ltd., and Eurofarma Laboratórios S/A
Global Protein Tyrosine Kinase 7 Market Company Profile
- Novartis AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Bristol-Myers Squibb Company
- Pfizer Inc.
- Johnson & Johnson
- AstraZeneca Plc
- Bayer AG
- Boehringer Ingelheim International GmbH
- F. Hoffmann-La Roche Ltd.
- Eisai Co., Ltd.
- Eurofarma Laboratórios S/A
“*” marked represents similar segmentation in other categories in the respective section
Global Protein Tyrosine Kinase 7 Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for Protein Tyrosine Kinase 7 Strategies
- Key Questions this Study will Answer
- Market Snippet, By Product
- Market Snippet, By Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Global Protein Tyrosine Kinase 7 Market, By Product, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Epidermal growth factor receptor tyrosine kinase inhibitor
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- BCR- ABL Tyrosine kinase inhibitor
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Vascular Endothelial growth factor tyrosine kinase inhibitor
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Protein Tyrosine kinase 7 Market, By Application, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Lung cancer
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Chronic Myeloid leukemia
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Renal cell cancer
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Breast cancer
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Protein Tyrosine Kinase 7 Market, By Distribution Channel, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Hospital pharmacies
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Online pharmacies
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Independent pharmacies
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Protein Tyrosine Kinase 7 Market, By Region, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Patients, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Patients, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
-
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Patients, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Patients, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Patients, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- Novartis AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Bristol-Myers Squibb Company
- Pfizer Inc.
- Johnson & Johnson
- AstraZeneca Plc
- Bayer AG
- Boehringer Ingelheim International GmbH
- F. Hoffmann-La Roche Ltd.
- Eisai Co., Ltd.
- Eurofarma Laboratórios S/A
The Last Word
-
- Future Impact
- About Us
- Contact
FAQs
The global protein tyrosine kinase 7 market is segmented based on product, application, distribution channel and region.
Increased recognition of kinase inhibitors, a boom in product approvals, an increase in the incidence of cancer diseases, and increased investment from pharmaceutical companies are some of the main factors driving market growth.
The market is expected to be dominated by North America. North America's market is largely driven by the high cost of TKIs and high health-care spending.
Companies are continuously rising the production and increasing the investment into the market’s growth. Novartis AG and Bristol -Myers Squibb company are the major key players in the market.